Brought to you by 
Celgene takes a stake in PharmAkea with an option to acquire; helps propel drug discovery efforts
29 Mar 2021
Executive Summary
Celgene Corp. took an equity stake in fibrotic disease- and cancer-focused start-up PharmAkea Therapeutics Inc., and committed to help the company discover and develop new small-molecule therapeutics.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com